November 9, 2020 by Jeffrey Woldt
AmerisourceBergen, Bob Mauch
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Bob Mauch, group president of AmerisourceBergen and chairman of the Healthcare Distribution Alliance, talks about pharmaceutical distributors’ contributions to the health care system. The durability, reliability and safety of the supply chain, partnerships between wholesalers and retail pharmacy operators, and HDA’s plans for a strategic refresh are among the subjects
November 9, 2020 by Jeffrey Woldt
Chris Dimos, McKesson Corp., Nimesh Jhaveri
November 9, 2020, Opinion
McKesson Corp. is going from strength to strength as it realigns the team that provides support to pharmacy operators across the country. In the wake of Chris Dimos’ retirement as president of retail solutions, the drug wholesaler has named Nimesh Jhaveri president of community pharmacy, and Eyad Farah president of Health Mart and Health Mart
November 2, 2020 by Jeffrey Woldt
Jeffrey Woldt editor-in-chief Chain Drug Review, Jon Roberts CVS Health, Video Forum
Featured Articles, Leading Headlines, Videos
In this week’s Video Forum, Jon Roberts, chief operating officer of CVS Health, discusses the company’s unique health care model and its performance during the COVID-19 crisis. He also addresses the response of patients and payers to CVS’ HealthHUB format, the important place that front-end merchandise has in the company’s retail strategy, and the impact
October 26, 2020 by Jeffrey Woldt
Care Pharmacies, Mike Wysong
Featured Articles, Leading Headlines, Videos
For five of the past six years, Care Pharmacies has earned a place on the National Retail Federation’s Hot 100 list. In this week’s Video Forum, Mike Wysong, the company’s chief executive officer, talks about the reasons behind Care’s robust growth, collaboration among its members, and efforts to bolster sales outside the pharmacy department.
October 19, 2020 by Jeffrey Woldt
Clint Mahlman London Drugs, Jeffrey Woldt editor-in-chief Chain Drug Review
Featured Articles, Leading Headlines, Videos
Clint Mahlman, president and chief operating officer of London Drugs, tells this week’s Video Forum how the drug chain’s unique business model meets a variety of needs for consumers in Western Canada, especially during the COVID-19 outbreak. He also discusses the boom in e-commerce, an area in which London Drugs has more than two decades
October 19, 2020 by Jeffrey Woldt
Bartell Drugs, Rite Aid
October 19, 2020, Opinion
The pending purchase of Bartell Drugs by Rite Aid reflects the intensification of two significant long-term trends in retail pharmacy and health care. The $95 million transaction, which still must pass muster with government regulators, will add the 67 stores that Bartell operates in Seattle and surrounding King, Snohomish and Pierce counties to the 69
October 15, 2020 by Jeffrey Woldt
Eyad Farah, Healthmart, McKesson Corp., Nimesh Jhaveri
Featured Articles, Leading Headlines, Pharmacy
IRVING, Texas — McKesson Corp. is going from strength to strength as it realigns the team that provides support to pharmacy operators across the country. In the wake of Chris Dimos’ retirement as president of retail solutions, the drug wholesaler has named Nimesh Jhaveri president of community pharmacy, and Eyad Farah president of Health Mart
October 5, 2020 by Jeffrey Woldt
Debbie Weitzman, president of U.S. Pharmaceutical Distribution at Cardinal Health
Featured Articles, Leading Headlines, Pharmacy, Videos
In this week’s installment of our Video Forum, Debbie Weitzman, president of U.S. Pharmaceutical Distribution at Cardinal Health, talks about the company’s commitment to supporting all aspects of the pharmacy profession. Among the subjects covered are Cardinal’s expanding range of capabilities, the health care system’s performance during the COVID-19 pandemic, and the benefits of allowing
October 5, 2020 by Jeffrey Woldt
COVID-19
October 5, 2020, Opinion
The Trump administration’s fitful response to COVID-19 has failed to meet the moment, one in which a pandemic the likes of which has not been seen in a century threatens the well-being and livelihood of millions of Americans. As this issue of Chain Drug Review was about to go to press, more than 6.9 million
September 28, 2020 by Jeffrey Woldt
chief executive officer B. Douglas Hoey, DIR, NCPA, Video Forum
Featured Articles, Leading Headlines, Pharmacy, Videos
In this week’s Video Forum, Doug Hoey, chief executive officer of the National Community Pharmacists Association, talks about some of the issues confronting independent drug stores and the larger pharmacy sector. Scope of practice, DIR fees, and Rutledge vs. PCMA, which will be taken up by the Supreme Court in October, are among the subjects
September 23, 2020 by Jeffrey Woldt
Dark & Lovely, L’Oréal USA Consumer Products division, Nathalie Gerschtein
Leading Headlines, September 21, 2020, Supplier News
The outbreak of COVID-19 at the start of the year and subsequent efforts to control the virus created much uncertainty in the beauty care business, but did little to disturb the preeminence of L’Oréal. Under the direction of president Nathalie Gerschtein, the L’Oréal USA Consumer Products division adapted quickly to changing dynamics in the marketplace,
September 21, 2020 by Jeffrey Woldt
McKesson, Video Forum: Chris Dimos
Featured Articles, Leading Headlines, Videos
On the verge of his retirement from McKesson Corp., Chris Dimos, president of retail solutions, talks about the company’s evolution, how to unlock the full potential of community pharmacy, and his plans for the future.
September 21, 2020 by Jeffrey Woldt
Doug McMillon, Walmart
Opinion, September 21, 2020
In a recent video marking the first anniversary of the Business Roundtable’s adoption of a revised statement of purpose for a corporation, Walmart CEO Doug McMillon spoke about how the new definition — which was expanded from a tight focus on shareholders to one that also includes customers, employees, suppliers and communities — reflects the
September 21, 2020 by Jeffrey Woldt
global sustainability, Jeffrey Woldt editor-in-chief Chain Drug Review
Opinion, September 21, 2020
CDR SPECIAL REPORT — Since the beginning of the COVID-19 pandemic, the momentum behind the sustainability movement has slowed somewhat, with the attention of government officials, activists and average citizens dominated by the immediate crisis and the concurrent drive for racial justice. The climate emergency has not, however, abated, a reality brought home to Americans